Additionally, HA has been demonstrated to promote HNSCC progression by promoting the association of CD44 with EGFR with a subsequent enhanced activation of EGFR and the downstream MAPK pathway, one of the most altered pathways in HNSCC [150]. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.